Key Highlights

  • Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) traded about 351 million shares as it rose 290.33% to USD 0.7471 after redeeming all Series C preferred stock.
  • Baird Medical Investment Holdings Limited (NASDAQ:BDMD) traded about 108.64 million shares and rose 20.26% despite a Nasdaq bid price letter.
  • Zeta Network Group (NASDAQ:ZNB) rose 73.7% on about 61.08 million shares, with cash of about USD 44,000 at June 30, 2026.
  • Elong Power Holding Limited (NASDAQ:ELPW) rose 44.31% on about 46.71 million shares after a framework deal of at least RMB 2 billion.

Lakewood-Amedex Biotherapeutics (NASDAQ:LABT): 351 Million Shares Change Hands

Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) tops the Volume table with about 351 million shares traded, alongside a gain of 290.33% to USD 0.7471 in trading on November 5, 2026, per published market data. The company announced at 8:02 a.m. ET that day that it had completed the Redemption of all 127,097 remaining Series C Preferred Shares for USD 1,270,970 in cash, under an agreement dated November 2, 2026 with Shakawe Capital LLC. The payment works out to USD 10 per preferred share, simple arithmetic on two published numbers. Management says no preferred stock and no borrowed-money Debt remain outstanding. The market reading is that convertible preferred can convert into common shares at a discount, so retiring it removes a source of future selling and dilution. The trade-off is cash: money paid out for the redemption may shorten the runway of a clinical-stage company that has no product Revenue described here. Filings in August and September 2026 are mentioned in published coverage, and Market Value figures conflict across pages and are omitted. The risks are reduced runway, future dilution, a thin float and clinical results, and a quoted move of this size can reverse quickly.

Baird Medical Investment Holdings Limited (NASDAQ:BDMD): 108.64 Million Shares and a Bid Price Letter

Baird Medical Investment Holdings Limited (NASDAQ:BDMD) ranks second by volume, with about 108.64 million shares traded as the stock rose 20.26% to USD 0.1312 in trading on November 5, 2026, per published market data. The trigger for attention is a Nasdaq minimum bid price deficiency letter dated November 2, 2026 and announced on November 4, 2026. The company has 180 calendar days, until May 3, 2027, to restore a closing bid of USD 1.00 for at least ten consecutive Business days. That bar sits more than seven times above the current quote, simple arithmetic. On November 4, 2026 the company said it knew of no material development or undisclosed reason behind its recent share price decline, which means the volume is not tied to a stated business event. No financial results were located and no reverse split has been announced. Heavy turnover in a sub-dollar stock often reflects speculative trading rather than new information, and it can reverse as fast as it built. If the bid stays low, a reverse split or delisting proceedings follow, and a split often brings dilution. Published market data puts the market value near USD 4.2 million.

Zeta Network Group (NASDAQ:ZNB): 61 Million Shares on Unconfirmed AI Coverage

Zeta Network Group (NASDAQ:ZNB) jumped 73.7% to USD 1.0804 in trading on November 5, 2026, per published market data, on volume of about 61.08 million shares. Published coverage linked the move to an AI infrastructure expansion, which is a single-source claim and unconfirmed. The latest filing is the fiscal 2026 Annual Report on Form 20-F for the year to June 30, 2026. It shows revenue of about USD 28.4 million, up 225%, but a net loss of about USD 157.5 million, including a USD 114.0 million Impairment on SolvBTC. Cash stood at about USD 44,000, and management says there is substantial doubt about the company continuing as a going concern. The company did a 100-for-1 reverse split on March 12, 2026 and an 8-for-1 reverse split on July 27, 2026, and has notes of up to USD 10 million, with a first close of USD 6 million. A Going Concern warning means the company may not be able to fund operations for a year without new capital, which usually means new shares. A rise of 73.7% on heavy volume in a nano-cap can reverse sharply, and crypto exposure adds volatility.

Elong Power Holding Limited (NASDAQ:ELPW): 46.71 Million Shares on a Framework Deal

Elong Power Holding Limited (NASDAQ:ELPW) traded 44.31% higher at USD 3.62 in trading on November 5, 2026, per published market data, on volume of about 46.71 million shares. The company announced a three-year cooperation agreement calling for procurement of no less than RMB 2 billion, about USD 300 million, of energy storage equipment. A first purchase contract of no less than RMB 300 million, about USD 45 million, is scheduled for signing in January 2027. Those are intentions, not signed orders, and the counterparty is unnamed. A framework agreement sets terms for future purchases but does not guarantee them. Published market data puts the market value near USD 3.38 million, a fraction of the headline contract value, which explains some of the excitement and also why caution is warranted. The company had announced a USD 25.5 million distribution agreement on October 28, 2026, and sold its lithium battery Subsidiary in March 2026. First-half revenue was USD 2.9 million, margins were described as near zero in published coverage, and a 1-for-45 reverse split took effect on August 10, 2026. Dilution and Reversal risk apply.

Fly-E Group, Inc. (NASDAQ:FLYE): 22.85 Million Shares on Heavy Volume

Fly-E Group, Inc. (NASDAQ:FLYE) rounds out the volume list with 22.85 million shares traded as the stock rose 30.58% to USD 2.22 in trading on November 5, 2026, per published market data. No same-day filing explaining the volume was identified. The latest major update is fiscal 2026 results on July 24, 2026, along with a Nasdaq listing notice whose reason was not reviewed. Net revenues fell 25.0% to USD 19.1 million from USD 25.4 million, gross Margin slid to 24.4% from 41.1% and the net loss widened to USD 9.3 million from USD 5.3 million, or USD 8.38 per share. Cash at March 31, 2026 was USD 0.3 million, down from USD 0.8 million. Strong turnover with weak financials is a mismatch that tends to resolve through price, and quoted gains can reverse. A company with little cash may sell new shares, and heavy volume can give it a window. Store closures, listing notices and dilution are the named risks. Quarterly results after fiscal 2026 were not retrieved, and the details of any reverse splits were not found.

Where Things Stand

The heaviest volume on November 5, 2026 sat with nano-cap and micro-cap names where activity ran ahead of verified information: a preferred redemption, a bid price letter, unconfirmed AI coverage, a framework deal and an unexplained spike. The balance of evidence is weak, because volume measures attention and not fundamentals, and every move here can reverse. Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) has the clearest catalyst in a filed redemption. Baird Medical Investment Holdings Limited (NASDAQ:BDMD) has a compliance clock to May 3, 2027. Zeta Network Group (NASDAQ:ZNB) carries a going concern warning. Elong Power Holding Limited (NASDAQ:ELPW) rests on unsigned purchases. Fly-E Group, Inc. (NASDAQ:FLYE) has little cash. Confirmation, funding and dilution are the next items to watch.